STAAR Surgical to Report First Quarter Results on May 7, 2024

Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating

Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?

Staar Surgical, A Lasik Rival, Just Crushed Quarterly Views; But Is Its 2026 Target Too Aggressive?

Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus

Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)

STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024

STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024

Nvidia’s Market Cap Myopia: 3 Stocks Proving Size Isn’t Everything

These two 'hidden gems' in health care are set to rally, Jefferies says

STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses

The past three years for STAAR Surgical (NASDAQ:STAA) investors has not been profitable

STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses

Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?

STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors

Here are Monday's biggest analyst calls: Nvidia, Tesla, Netflix, Adobe, Amazon, Eli Lilly, Procter & Gamble & more

STAAR Surgical to Participate in Two Upcoming Investor Conferences